![](https://agenda.euractiv.com/sites/default/files/styles/ea_company_list/public/rsz_european_cleaning_days_final.jpg?itok=MkRV7gHn)
EUnited Competitiveness Review Dinner Debate
Date
Address
Event Type
Organiser type
Section
Event Location
Event Description
EUnited Competitiveness Review Dinner Debate, Tuesday 5 November 2013, Bibliotheque Solvay, Brussels.
“What does the EU-US Transatlantic Trade and Investment Partnership (TTIP) mean for manufacturing? How can European companies anticipate and acquire competitive advantages in Europe and other world regions?”
Panel Guests: Damien Levie, EC Trade, Reinhard Bütikofer MEP, Elena Bryan, US Mission to EC and industry specialists. Moderator Dirk Sterckx former MEP & TV journalist
For more information contact info@eu-nited.net
Related Events
Securing Europe‘s Raw Material Supply in the Context of Resource Efficiency and EU Industry Policy
There is no energy- and resource efficiency, no climate protection, no future technologies for our modern
world without the use of non-ferrous metals.
Monday 5 November 2012 (day 1)
15:00-16:30: European Parliament Briefing (optional): Enterprise Forum members will have the opportunity to attend a briefing on how the European Parliament works. Paul-Henri Spaak Building, Rue Wiertz, B-1047 Brussels
SMEs are the backbone of the European economy. Of the approximately 20 million SMEs in Europe, one third is active in the field of commerce.
COST will be a partner of the fourth European Innovation Summit to be held at the European Parliament in Brussels under the motto 'Building bridges – Creating Synergies'.
Knowledge4Innovation will be organising the 4th European Innovation Summit from 9 to 10 October 2012 in the European Parliament in Brussels.
An existing literature agrees that drug innovation has a significant average effect on extending longevity and improving quality of life. Recognizing the life-saving benefits from the development of new drugs, one of the key decisions faced by the authorities is how to bolster pharmaceutical innovation, and how to bear in mind the potential effects on drug innovation of policies that affect market size, such as policies towards intellectual property rights, procurement mechanisms and competition policy.
Pages
Events of the week
Jobs
EURACTIV News
- Left-wing parties launch impeachment proceedings against Emmanuel Macron
- Future-proofing the EU’s road transport sector: a roadmap for policymaker action [Promoted content]
- Sanchez hails ‘greatest-ever’ influence on Brussels after Ribera portfolio reveal
- New position, same old tasks for the defence commissioner
- Swedish environment commissioner “happy” but faces tough hearing on forestry, climate goals